It is currently recognized that the pathogenesis of malig-nancy-associated thrombotic microangiopathy (TMA) is distinct from thrombotic thrombocytopenic purpura. This carries important implications in its classification and its management. Here, we report a case of occult malignancy presenting initially as acute kidney injury secondary to TMA and highlight the importance of considering an underlying malignancy in patients not responding to con-ventional therapy for TMA
Cancer-related thrombotic microangiopathy (TMA) is a rare entity whose clinical and biological chara...
Objective. The current study aimed to investigate the spectrum of etiologies and associated disorder...
Background. Thrombotic microangiopathies (TMA) are relatively rare but severe disorders characterise...
Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consu...
This report, based on data from a clinical case, proposes that pulmonary tumor thrombotic microangio...
Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are clinically similar...
This report, based on data from a clinical case, proposes that pulmonary tumor thrombotic microangio...
Five patients with carcinoma developed thrombotic microangiopathy (characterized by renal insufficie...
Monoclonal gammopathies result from neoplastic clones of the B-cell lineage and may cause kidney dis...
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolyti...
Copyright © 2012 S. Regragui et al. This is an open access article distributed under the Creative Co...
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. The ...
Microangiopathic hemolytic anemia (MAHA) is a late hut fatal complication in advanced cancers. In th...
A pathological process of microvascular thrombosis, microangiopathic hemolytic anemia and thrombocyt...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...
Cancer-related thrombotic microangiopathy (TMA) is a rare entity whose clinical and biological chara...
Objective. The current study aimed to investigate the spectrum of etiologies and associated disorder...
Background. Thrombotic microangiopathies (TMA) are relatively rare but severe disorders characterise...
Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consu...
This report, based on data from a clinical case, proposes that pulmonary tumor thrombotic microangio...
Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are clinically similar...
This report, based on data from a clinical case, proposes that pulmonary tumor thrombotic microangio...
Five patients with carcinoma developed thrombotic microangiopathy (characterized by renal insufficie...
Monoclonal gammopathies result from neoplastic clones of the B-cell lineage and may cause kidney dis...
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolyti...
Copyright © 2012 S. Regragui et al. This is an open access article distributed under the Creative Co...
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. The ...
Microangiopathic hemolytic anemia (MAHA) is a late hut fatal complication in advanced cancers. In th...
A pathological process of microvascular thrombosis, microangiopathic hemolytic anemia and thrombocyt...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...
Cancer-related thrombotic microangiopathy (TMA) is a rare entity whose clinical and biological chara...
Objective. The current study aimed to investigate the spectrum of etiologies and associated disorder...
Background. Thrombotic microangiopathies (TMA) are relatively rare but severe disorders characterise...